Stocktoria
COOPER COMPANIES, INC. COO
Nasdaq · XNAS · stock · Ophthalmic Goods · website · IPO 1983-01-21
COOPER COMPANIES, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $4.1B | $3.9B | $3.6B | $3.3B | $2.9B |
| Gross profit | $2.7B | $2.6B | $2.4B | $2.1B | $2.0B |
| R&D expense | $172.2M | $155.1M | $137.4M | $110.3M | $92.7M |
| SG&A expense | $1.6B | $1.5B | $1.5B | $1.3B | $1.2B |
| Operating income | $682.9M | $705.7M | $533.1M | $507.6M | $505.8M |
| Interest expense | — | — | $105.3M | $57.3M | $23.1M |
| Income tax | $191.6M | $190.0M | $118.7M | $89.5M | -$2.5B |
| Net income | $374.9M | $392.3M | $294.2M | $385.8M | $2.9B |
| EPS (diluted) | $1.87 | $1.96 | $1.48 | $1.94 | $59.16 |
| Operating cash flow | $796.1M | $709.3M | $607.5M | $692.4M | $738.6M |
| Free cash flow | $433.7M | $288.1M | $215.0M | $450.4M | $524.2M |
| Cash & equivalents | $110.6M | $107.6M | $120.8M | $138.2M | $95.9M |
| Inventory | $846.0M | $802.7M | $735.6M | $628.7M | $585.6M |
| Total assets | $12.4B | $12.3B | $11.7B | $11.5B | $9.6B |
| Total liabilities | $4.2B | $4.2B | $4.1B | $4.3B | $2.7B |
| Shareholders' equity | $8.2B | $8.1B | $7.6B | $7.2B | $6.9B |
Source: SEC EDGAR filings · CIK 0000711404 · as of 2025-10-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.